Apatinib + CPT-11 + S-1 for treatment of refractory brain metastases in patient with triple-negative breast cancer: Case report and literature review

RATIONALE: Brain metastasis (BM) is a rising challenge in forward-looking oncology, as its treatment choices are very limited, especially, after the failure of local treatment schemes. PATIENT CONCERNS: We report on a 39-year-old Chinese woman who was diagnosed with stage IV triple-negative breast c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ting, Liu, Cuiwei, Li, Qiuhui, Xiong, Jie, Ma, Yuxi, Wu, Gang, Zhao, Yanxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908627/
https://www.ncbi.nlm.nih.gov/pubmed/29642175
http://dx.doi.org/10.1097/MD.0000000000010349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908627/
https://www.ncbi.nlm.nih.gov/pubmed/29642175
http://dx.doi.org/10.1097/MD.0000000000010349

Ejemplares similares